+Search query
-Structure paper
Title | Discovery and Characterization of Brigimadlin, a Novel and Highly Potent MDM2-p53 Antagonist Suitable for Intermittent Dose Schedules. |
---|---|
Journal, issue, pages | Mol. Cancer Ther., Vol. 23, Page 1689-1702, Year 2024 |
Publish date | Jul 20, 2023 (structure data deposition date) |
![]() | Gollner, A. / Rudolph, D. / Weyer-Czernilofsky, U. / Baumgartinger, R. / Jung, P. / Weinstabl, H. / Ramharter, J. / Grempler, R. / Quant, J. / Rinnenthal, J. ...Gollner, A. / Rudolph, D. / Weyer-Czernilofsky, U. / Baumgartinger, R. / Jung, P. / Weinstabl, H. / Ramharter, J. / Grempler, R. / Quant, J. / Rinnenthal, J. / Perez Pitarch, A. / Golubovic, B. / Gerlach, D. / Bader, G. / Wetzel, K. / Otto, S. / Mandl, C. / Boehmelt, G. / McConnell, D.B. / Kraut, N. / Sini, P. |
![]() | ![]() ![]() |
Methods | X-ray diffraction |
Resolution | 1.461 Å |
Structure data | ![]() PDB-8pwc: |
Chemicals | ![]()
ChemComp-G7I: ![]() ChemComp-HOH: |
Source |
|
![]() | LIGASE / Inhibitor / Complex |